The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Outcome Assessment (Health Care)

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Outcome Assessment (Health Care)


Psychiatry related information on Outcome Assessment (Health Care)


High impact information on Outcome Assessment (Health Care)

  • As compared with placebo, secretin treatment was not associated with significant improvements in any of the outcome measures [11].
  • The primary outcome measure, airway responsiveness (as assessed with a methacholine challenge) was evaluated before treatment; after 3, 6, 9, and 12 months of treatment (12 and 36 hours after study medications had been withheld); and 2 weeks after the end of treatment [12].
  • For complex partial seizures, four of five outcome measures favored carbamazepine (100 patients) over valproate (106 patients): the total number of seizures (2.7 vs. 7.6, P = 0.05), the number of seizures per month (0.9 vs. 2.2, P = 0.01), the time to the first seizure (P less than 0.02), and the seizure-rating score (P = 0.04) [13].
  • MAIN OUTCOME MEASURES: Occurrence of more than a 25% increase in serum creatinine level within 48 hours after contrast administration; change in creatinine clearance and serum creatinine level [14].
  • MAIN OUTCOME MEASURES: The primary outcome measure was the 1-year change in the Alzheimer Disease Assessment Scale-Cognitive (ADAS-Cog) subscale score [15].

Chemical compound and disease context of Outcome Assessment (Health Care)


Biological context of Outcome Assessment (Health Care)


Anatomical context of Outcome Assessment (Health Care)


Associations of Outcome Assessment (Health Care) with chemical compounds


Gene context of Outcome Assessment (Health Care)


Analytical, diagnostic and therapeutic context of Outcome Assessment (Health Care)


  1. Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection. Ross, K.S., Carter, H.B., Pearson, J.D., Guess, H.A. JAMA (2000) [Pubmed]
  2. A prospective study of folate intake and the risk of breast cancer. Zhang, S., Hunter, D.J., Hankinson, S.E., Giovannucci, E.L., Rosner, B.A., Colditz, G.A., Speizer, F.E., Willett, W.C. JAMA (1999) [Pubmed]
  3. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. Wechsler, M.E., Garpestad, E., Flier, S.R., Kocher, O., Weiland, D.A., Polito, A.J., Klinek, M.M., Bigby, T.D., Wong, G.A., Helmers, R.A., Drazen, J.M. JAMA (1998) [Pubmed]
  4. Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000). Kanda, Y., Chiba, S., Hirai, H., Sakamaki, H., Iseki, T., Kodera, Y., Karasuno, T., Okamoto, S., Hirabayashi, N., Iwato, K., Maruta, A., Fujimori, Y., Furukawa, T., Mineishi, S., Matsuo, K., Hamajima, N., Imamura, M. Blood (2003) [Pubmed]
  5. Combination therapy with thymosin alpha1 and interferon for the treatment of chronic hepatitis C infection: a randomized, placebo-controlled double-blind trial. Sherman, K.E., Sjogren, M., Creager, R.L., Damiano, M.A., Freeman, S., Lewey, S., Davis, D., Root, S., Weber, F.L., Ishak, K.G., Goodman, Z.D. Hepatology (1998) [Pubmed]
  6. Acetaminophen and other risk factors for excessive warfarin anticoagulation. Hylek, E.M., Heiman, H., Skates, S.J., Sheehan, M.A., Singer, D.E. JAMA (1998) [Pubmed]
  7. Behavior therapy, supportive psychotherapy, imipramine, and phobias. Zitrin, C.M., Klein, D.F., Woerner, M.G. Arch. Gen. Psychiatry (1978) [Pubmed]
  8. Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder. Liebowitz, M.R., Gelenberg, A.J., Munjack, D. Arch. Gen. Psychiatry (2005) [Pubmed]
  9. Quality of life of people with rheumatoid arthritis as measured by the World Health Organization Quality of Life Instrument, short form (WHOQOL-BREF): score distributions and psychometric properties. Taylor, W.J., Myers, J., Simpson, R.T., McPherson, K.M., Weatherall, M. Arthritis Rheum. (2004) [Pubmed]
  10. Smoking cessation in hospitalized patients. Results of a randomized trial. Miller, N.H., Smith, P.M., DeBusk, R.F., Sobel, D.S., Taylor, C.B. Arch. Intern. Med. (1997) [Pubmed]
  11. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. Sandler, A.D., Sutton, K.A., DeWeese, J., Girardi, M.A., Sheppard, V., Bodfish, J.W. N. Engl. J. Med. (1999) [Pubmed]
  12. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. Simons, F.E. N. Engl. J. Med. (1997) [Pubmed]
  13. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. Mattson, R.H., Cramer, J.A., Collins, J.F. N. Engl. J. Med. (1992) [Pubmed]
  14. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. Kay, J., Chow, W.H., Chan, T.M., Lo, S.K., Kwok, O.H., Yip, A., Fan, K., Lee, C.H., Lam, W.F. JAMA (2003) [Pubmed]
  15. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. Aisen, P.S., Schafer, K.A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K.L., Farlow, M.R., Jin, S., Thomas, R.G., Thal, L.J. JAMA (2003) [Pubmed]
  16. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arnold, L.M., Lu, Y., Crofford, L.J., Wohlreich, M., Detke, M.J., Iyengar, S., Goldstein, D.J. Arthritis Rheum. (2004) [Pubmed]
  17. Diabetes in urban African Americans. III. Management of type II diabetes in a municipal hospital setting. Ziemer, D.C., Goldschmid, M.G., Musey, V.C., Domin, W.S., Thulé, P.M., Gallina, D.L., Phillips, L.S. Am. J. Med. (1996) [Pubmed]
  18. Factors associated with implementation of preventive care measures in patients with diabetes mellitus. Streja, D.A., Rabkin, S.W. Arch. Intern. Med. (1999) [Pubmed]
  19. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. Ward, M.M., Studenski, S. Arch. Intern. Med. (1992) [Pubmed]
  20. Multicenter, placebo-controlled study of fluoxetine in seasonal affective disorder. Lam, R.W., Gorman, C.P., Michalon, M., Steiner, M., Levitt, A.J., Corral, M.R., Watson, G.D., Morehouse, R.L., Tam, W., Joffe, R.T. The American journal of psychiatry. (1995) [Pubmed]
  21. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. Weiskopf, R.B., Viele, M.K., Feiner, J., Kelley, S., Lieberman, J., Noorani, M., Leung, J.M., Fisher, D.M., Murray, W.R., Toy, P., Moore, M.A. JAMA (1998) [Pubmed]
  22. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Koren, M.J., Devereux, R.B., Casale, P.N., Savage, D.D., Laragh, J.H. Ann. Intern. Med. (1991) [Pubmed]
  23. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Epperson, C.N., Haga, K., Mason, G.F., Sellers, E., Gueorguieva, R., Zhang, W., Weiss, E., Rothman, D.L., Krystal, J.H. Arch. Gen. Psychiatry (2002) [Pubmed]
  24. Chelation therapy for intermittent claudication. A double-blind, randomized, controlled trial. van Rij, A.M., Solomon, C., Packer, S.G., Hopkins, W.G. Circulation (1994) [Pubmed]
  25. Clinical responses to tumor necrosis factor alpha antagonists do not show a bimodal distribution: data from the Stockholm tumor necrosis factor alpha followup registry. van Vollenhoven, R.F., Klareskog, L. Arthritis Rheum. (2003) [Pubmed]
  26. Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randomized controlled trial. Anzueto, A., Jubran, A., Ohar, J.A., Piquette, C.A., Rennard, S.I., Colice, G., Pattishall, E.N., Barrett, J., Engle, M., Perret, K.A., Rubin, B.K. JAMA (1997) [Pubmed]
  27. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness. Hodis, H.N., Mack, W.J., Dunn, M., Liu, C., Liu, C., Selzer, R.H., Krauss, R.M. Circulation (1997) [Pubmed]
  28. Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study. Patel, N.K., Bunnage, M., Plaha, P., Svendsen, C.N., Heywood, P., Gill, S.S. Ann. Neurol. (2005) [Pubmed]
  29. Viral load differences in early infection with two HIV-1 subtypes. Hu, D.J., Vanichseni, S., Mastro, T.D., Raktham, S., Young, N.L., Mock, P.A., Subbarao, S., Parekh, B.S., Srisuwanvilai , L., Sutthent, R., Wasi, C., Heneine, W., Choopanya, K. AIDS (2001) [Pubmed]
  30. Effects of whey protein and resistance exercise on body cell mass, muscle strength, and quality of life in women with HIV. Agin, D., Gallagher, D., Wang, J., Heymsfield, S.B., Pierson, R.N., Kotler, D.P. AIDS (2001) [Pubmed]
  31. Diurnal variation in fasting plasma glucose: implications for diagnosis of diabetes in patients examined in the afternoon. Troisi, R.J., Cowie, C.C., Harris, M.I. JAMA (2000) [Pubmed]
  32. Effect of a garlic oil preparation on serum lipoproteins and cholesterol metabolism: a randomized controlled trial. Berthold, H.K., Sudhop, T., von Bergmann, K. JAMA (1998) [Pubmed]
  33. A longitudinal study of low-level lead exposure and impairment of renal function. The Normative Aging Study. Kim, R., Rotnitsky, A., Sparrow, D., Weiss, S., Wager, C., Hu, H. JAMA (1996) [Pubmed]
  34. Effects of alcohol ingestion on estrogens in postmenopausal women. Ginsburg, E.S., Mello, N.K., Mendelson, J.H., Barbieri, R.L., Teoh, S.K., Rothman, M., Gao, X., Sholar, J.W. JAMA (1996) [Pubmed]
  35. Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. Van Cauter, E., Leproult, R., Plat, L. JAMA (2000) [Pubmed]
  36. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. Ackerman, M.J., Siu, B.L., Sturner, W.Q., Tester, D.J., Valdivia, C.R., Makielski, J.C., Towbin, J.A. JAMA (2001) [Pubmed]
  37. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Williams, N.M., Preece, A., Morris, D.W., Spurlock, G., Bray, N.J., Stephens, M., Norton, N., Williams, H., Clement, M., Dwyer, S., Curran, C., Wilkinson, J., Moskvina, V., Waddington, J.L., Gill, M., Corvin, A.P., Zammit, S., Kirov, G., Owen, M.J., O'Donovan, M.C. Arch. Gen. Psychiatry (2004) [Pubmed]
  38. Pharmacology and efficacy of cyclooxygenase (COX) inhibitors. Furst, D.E. Am. J. Med. (1999) [Pubmed]
  39. Randomized, controlled phase II trial of subcutaneous interleukin-2 in combination with highly active antiretroviral therapy (HAART) in HIV patients. Hengge, U.R., Goos, M., Esser, S., Exner, V., Dötterer, H., Wiehler, H., Borchard, C., Müller, K., Beckmann, A., Eppner, M.T., Berger, A., Fiedler, M. AIDS (1998) [Pubmed]
  40. A homozygous mutation in the lamin A/C gene associated with a novel syndrome of arthropathy, tendinous calcinosis, and progeroid features. Van Esch, H., Agarwal, A.K., Debeer, P., Fryns, J.P., Garg, A. J. Clin. Endocrinol. Metab. (2006) [Pubmed]
  41. Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: a randomized trial. Smyth, J.M., Stone, A.A., Hurewitz, A., Kaell, A. JAMA (1999) [Pubmed]
  42. The spread of the obesity epidemic in the United States, 1991-1998. Mokdad, A.H., Serdula, M.K., Dietz, W.H., Bowman, B.A., Marks, J.S., Koplan, J.P. JAMA (1999) [Pubmed]
  43. Intensity of leg and arm training after primary middle-cerebral-artery stroke: a randomised trial. Kwakkel, G., Wagenaar, R.C., Twisk, J.W., Lankhorst, G.J., Koetsier, J.C. Lancet (1999) [Pubmed]
  44. Dopamine agonist monotherapy in Parkinson's disease. Clarke, C.E., Guttman, M. Lancet (2002) [Pubmed]
  45. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Wallace, R.J., Tanner, D., Brennan, P.J., Brown, B.A. Ann. Intern. Med. (1993) [Pubmed]
WikiGenes - Universities